Lung cancer biopsy study aims to improve genetic test success
NCT ID NCT05560776
First seen Jan 27, 2026 · Last updated Jun 16, 2026 · Updated 25 times
Summary
This study looks at people with suspected or confirmed non-small cell lung cancer who need a tissue sample for genetic testing. It compares taking 2 versus 3 samples from each lymph node during an ultrasound-guided biopsy to see which method gives enough material for testing. It also checks if a simple blood test (liquid biopsy) can find genetic changes that the tissue sample might miss. The goal is to improve how doctors collect samples to guide treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Institut Universitaire de Cardiologie et Pneumologie de Quebec
Québec, Quebec, G1V4G5, Canada
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.